20 February 2020
Our European team looks at what the CJEU decision in case C-688/17 may mean for national practice.
We look at medical device product liability, starting with an incident report to a regulator and following the potential issues that a manufacturer might face.
Paolo Parmigiano and Barbora Dubanská explore the latest CJEU judgment in relation to pay-for-delay settlement agreements.
Anja Lunze examines what the Opinion of Advocate General Giovanni Pitruzella says concerning supplementary protection certificates.
Kalina Skwiecińska and Agnieszka Sztoldman provide an overview of the changes to Polish industrial property law that recently came into effect.
Barbora Dubanská reports on what the conference had to say about a major healthcare hot topic – drug pricing.
A CRISPR Cas9 patent has its priority rejected by the Technical Board of Appeal, and there is a rare and successful application of the Crown use defence to infringement in the UK.